Crescent Capital Group, an alternative credit investment firm, provided a senior term loan to Germany’s 3B Scientific, a manufacturer and marketer of anatomical and biological teaching aids for medical simulation, healthcare and patient education, and science. Terms of the transaction were not disclosed.
3B Scientific was acquired in January 2017 by J. H. Whitney Capital Partners in an all-equity transaction.
“We are very pleased to work with J. H. Whitney Capital Partners and to support 3B Scientific as it continues to grow its position as a leader in the global healthcare education sector,” said Christine Vanden Beukel, managing director and head of Crescent’s European Specialty Lending strategy. “This transaction will give 3B Scientific a flexible capital structure that complements the company’s financial strategy and supports its next phase of growth.”
Crescent Capital Group invests at all levels of the capital structure, with a significant focus on below investment grade credit through strategies that invest in senior bank loans, high yield debt, mezzanine debt, distressed debt and other private debt securities.
